Allarity Therapeutics (NASDAQ:ALLR) has received a notice which confirms that the Co. has regained compliance with the minimum bid price requirement as set forth in Nasdaq’s Listing Rule. Nasdaq noted...
Source LinkAllarity Therapeutics (NASDAQ:ALLR) has received a notice which confirms that the Co. has regained compliance with the minimum bid price requirement as set forth in Nasdaq’s Listing Rule. Nasdaq noted...
Source Link
Comments